Axon is growing fast, with Q2 revenue up 35% and ARR up 39%, but the stock’s premium valuation keeps the call at Hold. The platform’s expanding software, devices, and AI ecosystem supports the long-term case.
Axon Enterprise (AXON) has built one of the strongest platform businesses in public-safety technology. Q2 2026 revenue reached $904M, up 35% year over year, while annual recurring revenue rose 39% to $1.6B and net revenue retention reached 126%. Software, connected devices, counter-drone systems, artificial intelligence, and emergency-response tools now reinforce one another rather than operating as isolated products.
The investment case rests on durable customer expansion. Future contracted bookings reached $15.1B, two major cities signed nine-figure agreements, and the company reported international and enterprise bookings at roughly three times the prior-year level. The opposing force is valuation. AXON trades at 204.2x trailing earnings, 61.0x forward earnings, 12.5x enterprise value to revenue, and a PEG ratio of 2.2. Those figures leave little room for execution mistakes.
For a moderate-risk investor with a medium-term horizon, the appropriate stance is Hold. The business deserves a premium because revenue growth remains above 30%, retention is strong, and the product ecosystem is expanding. The stock does not deserve an unlimited premium while GAAP profitability remains inconsistent, free-cash-flow yield is 0.9%, and 2025 net income fell to $124.9M from $377.0M.
Axon Enterprise is a Scottsdale, Arizona-based public-safety technology company founded in 1993 and listed on Nasdaq. It had approximately 5,100 employees and served law enforcement, corrections, federal agencies, international government entities, commercial enterprises, and consumers at the end of the reported period.
The company operates through Software and Services and Connected Devices. Software includes Axon Evidence, Records, Fusus, Draft One, Axon Assistant, Axon Standards, Axon Justice, Axon 911, and related cloud workflows. Connected Devices includes TASER energy devices, body cameras, fixed and in-car cameras, drones, counter-drone products, accessories, training hardware, and related services.
The 2025 revenue mix shows the platform transition clearly. Software and Sensors represented $1.2B, or 43.3% of revenue; TASER X2 represented $913.9M, or 32.9%; Axon Body represented $397.0M, or 14.3%; and Platform Solutions represented $265.9M, or 9.6%. The product mix is moving beyond a device sale toward a connected operating system for public safety.
Software and Services generated $398M in Q2 2026 revenue, up 36% year over year. Axon Evidence remains the foundation, but more than one-third of software revenue now comes from newer offerings such as real-time operations, Records, the AI Era Plan, counter-drone software, and Axon 911. That newer group grew roughly 70% year over year, with the AI Era Plan growing almost 700%.
Connected Devices produced $507M in Q2 revenue, up 35%. TASER 10, Axon Body 4, Dedrone, and other counter-drone products drove the result. Platform Solutions revenue increased 123% to $150M, with Dedrone accounting for much of the increase. Management said Dedrone surpassed $100M in quarterly revenue, turning a recent acquisition into a material product line.
The segment structure creates a useful cross-sell loop. Hardware places Axon into an agency's daily workflow, while software increases data usage, retention, and expansion potential. Q2 net revenue retention of 126% provides measurable evidence that existing customers are purchasing more products and services over time.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Axon Evidence is the flagship software layer. It captures, stores, manages, shares, and analyzes video and digital evidence, giving the company a position inside a mission-critical workflow. The 2025 investor presentation cited more than 60 million hours of recordings from Axon Body 3 and Body 4 cameras, 300,000 connected community cameras, and 1 million monthly Fusus livestreams.
The hardware side remains equally important. TASER devices, body cameras, in-car cameras, drones, and counter-drone systems supply the data that feeds the software platform. Management reported the highest quarterly TASER volume in company history and said cumulative TASER 10 bookings had already exceeded lifetime TASER 7 bookings.
This integrated design is more valuable than any individual device. A body camera sale is a hardware transaction. A body camera connected to evidence storage, records management, AI-assisted reporting, dispatch, and courtroom workflows is a recurring platform relationship.
Axon's innovation advantage comes from combining sensors, workflow software, and artificial intelligence. The company has deployed AI Auto-Tagging, AI Case Search, Attribute Search, Draft One, Axon Assistant, and AI-enabled emergency-response tools across its product portfolio. The 2025 presentation showed AI operating across Records, Body 4, Fusus, Dedrone, Evidence, Draft One, Axon Air, Fleet 3, Dispatch, and Justice.
The data advantage compounds with adoption. Each additional camera, recording, dispatch workflow, and case creates more activity inside the platform. This does not make Axon immune to competition, but it raises the operational cost of switching to a point solution. The company also said agencies were moving from other license-plate-reader vendors because of Axon's privacy controls and governance tools.
Trust is part of the moat. Axon handles sensitive evidence and public-safety data, so privacy controls, audit trails, and responsible AI design matter commercially as well as ethically. The 2025 10-K identifies cybersecurity, data integrity, regulatory compliance, and product obsolescence as material risks. A platform that loses customer trust would lose more than one contract.
Axon has been scaling operations while expanding its product range. Management said the company flattened its organization, reduced internal layers, and introduced targeted AI tools for employees. Regular hackathons and focused automation are intended to improve execution without deploying technology merely for appearance. Corporate jargon rarely earns its keep, but this operating model has a measurable test in the company's sustained 30% plus revenue growth.
Supply-chain pressure remains visible in the financial results. Management cited higher component costs, tariffs, memory costs, and substantial inventory investment. Q2 adjusted gross margin rose to 62.9%, helped by tariff refunds, while newer product mix reduced some of the benefit. Management maintained full-year adjusted EBITDA margin guidance of approximately 25.5% and said Q3 margins would absorb higher memory costs before improving in Q4.
Capital spending was $136.3M in 2025, and 2026 CapEx guidance was $160M to $190M. The company also expects inventory investment to moderate after 2026. That combination points to a business still funding expansion rather than harvesting mature cash economics.
Axon operates in public-safety technology, a market that spans digital evidence, body cameras, records management, emergency response, real-time operations, drones, and counter-drone systems. Axon's investor materials have cited a total addressable market of $52B, including $37B in the United States and $15B internationally. The company also stated that its $2.0B of 2024 revenue represented less than 2% of that market.
The fastest expansion areas sit outside the legacy TASER and evidence categories. Counter-drone products now serve public safety, enterprise campuses, data centers, federal agencies, and international customers. Axon was named a participant in a $1.5B Department of Homeland Security counter-UAS program, while Dedrone revenue surpassed $100M in the latest quarter.
The market is also shifting from standalone hardware toward connected systems. The global C5ISR market was estimated at $10.7B in 2024 and projected to reach $19.3B by 2029, a 12.5% compound annual growth rate. Axon is not a traditional defense prime, but its sensor fusion, command-center, communications, and counter-drone products align with that networked demand.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Government agencies remain the core customer base. Axon serves federal, state, local, international, and corrections customers, with purchases often tied to long procurement cycles and multi-year agreements. Q2 included two nine-figure municipal agreements, two eight-figure state corrections agreements, and the largest individual TASER order in company history.
The customer base is broadening. Management described international bookings as roughly three times the prior-year level and enterprise bookings at approximately the same rate. A customer also signed the first full-scope Axon 911 agreement using the combined Prepared and Carbyne capabilities. These wins expand Axon's addressable customer from police departments to corrections, civilian agencies, enterprise security teams, and emergency communications centers.
Customer depth matters more than logo count. More than 80% of customers deploy at least one integrated solution, and more than 40% subscribe to at least one premium solution beyond core TASER, body-camera, and evidence products. That adoption pattern supports the 126% net revenue retention rate reported in Q2.
Axon's competition is fragmented by product category. Motorola Solutions (MSI), Genetec, Digital Ally (DGLY), Reveal Media, WatchGuard, Safe Fleet, Versaterm, Oracle (ORCL), OpenText (OTEX), and Veritone (VERI) compete in cameras, digital evidence, and related software. Flock Safety, Genetec, Motorola Solutions, Rekor Systems (REKR), and other specialists compete in license-plate recognition.
Records and workflow competitors include Tyler Technologies (TYL), Mark43, CentralSquare, Hexagon, Oracle, and Motorola Solutions. Real-time operations competition includes Genetec, Motorola Solutions, Flock Safety, Hexagon, and specialized command-center vendors. In counter-drone, Axon faces defense and security companies such as Anduril, L3Harris Technologies (LHX), Lockheed Martin (LMT), Northrop Grumman (NOC), RTX (RTX), Saab, and Thales.
Axon's advantage is breadth. Most competitors own a product category or a software layer, while Axon connects cameras, evidence, records, dispatch, AI, drones, TASER devices, and emergency response. Motorola Solutions is the closest broad platform rival, but Axon's 35% Q2 revenue growth, 39% ARR growth, and 126% net retention show that the platform strategy is producing strong commercial momentum.
The macro backdrop supports spending on public-safety modernization, AI, autonomy, and counter-drone systems. Deloitte's aerospace and defense outlook cited AI and agentic AI as major industry shifts, while defense priorities increasingly include drones, counter-UAS, autonomy, cyber, and networked command systems. Those priorities align with Axon's Dedrone, Fusus, AI, and communications offerings.
Geopolitical conflict has made drone defense a more visible budget category. Management cited the wars involving Russia and Ukraine and the Middle East when describing counter-drone demand, while also pointing to data centers, corporate campuses, sports venues, and executive security as commercial use cases. The World Cup acted as an accelerator, but Dedrone's customers were already repurposing World Cup equipment for other deployments.
The main macro risks are procurement timing, government budget pressure, tariffs, and regulation. Axon's 2025 10-K identifies government contracting, cybersecurity, privacy, product liability, and technology changes as material risks. Public-safety technology also carries reputational and political sensitivity, making trust and compliance a central part of the investment case.
Axon ended the period with a B- balance sheet profile, reflecting solid operating scale but not enough cushion to offset its elevated valuation risk.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q2 2026 revenue climbed 35% to $904M and annual recurring revenue rose 39% to $1.6B, showing strong top-line momentum across the platform.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Future contracted bookings reached $15.1B and net revenue retention hit 126%, pointing to continued expansion in software and connected devices.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At 204.2x trailing earnings, 61.0x forward earnings, and 12.5x EV/revenue, Axon’s premium leaves little room for disappointment.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report’s valuation framework supports a Hold stance, with fair value set at $550 and upside reserved for stronger execution.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Axon Enterprise has evolved from a TASER and body-camera company into a connected public-safety platform. Q2 2026 confirmed the strength of that transition: revenue grew 35%, ARR rose 39%, retention reached 126%, Platform Solutions grew 123%, and management raised full-year revenue growth guidance to 32% to 34%.
The stock's weakness is not the business model. It is the price paid for that business model. With a 204.2x trailing P/E, a 61.0x forward P/E, uneven GAAP earnings, and a modest free-cash-flow yield, AXON requires patience and valuation discipline. The Hold recommendation captures both realities: a durable platform with substantial growth runway, and a stock whose next leg higher depends on earnings catching up with the story.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Axon Enterprise, Inc. (AXON) rises after pricing a $1.0 billion 0% convertible notes offering due 2031. Investors are reacting to the financing as growth capital, supported by strong revenue momentum, while still weighing dilution risk and a rich valuation.
Axon Enterprise, Inc. (AXON) drops sharply after announcing a $1.0 billion convertible notes offering, sparking dilution concerns. The selloff comes despite strong revenue growth, solid earnings, and upbeat analyst sentiment, highlighting how financing risk can pressure a richly valued stock.
Axon’s latest pullback looks like the market punishing an expensive stock, not a business losing momentum. Revenue grew 34%, ARR grew 35%, and management raised 2026 guidance, which is not what a broken story looks like.